3:
Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.
Ignatiadis M, Kallergi G, Ntoulia M, Perraki M, Apostolaki S, Kafousi M, Chlouverakis G, Stathopoulos E, Lianidou E, Georgoulias V, Mavroudis D.
Clin Cancer Res. 2008 May 1;14(9):2593-600.
PMID: 18451221 [PubMed - indexed for MEDLINE]
Related Articles
8:
Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
Apostolaki S, Perraki M, Kallergi G, Kafousi M, Papadopoulos S, Kotsakis A, Pallis A, Xenidis N, Kalmanti L, Kalbakis K, Agelaki S, Kalykaki A, Stournaras C, Stathopoulos E, Georgoulias V, Mavroudis D.
Breast Cancer Res Treat. 2008 Nov 19. [Epub ahead of print]
PMID: 19016323 [PubMed - as supplied by publisher]
Related Articles
17:
Monitoring serial changes in circulating human breast cancer cells in murine xenograft models.
Eliane JP, Repollet M, Luker KE, Brown M, Rae JM, Dontu G, Schott AF, Wicha M, Doyle GV, Hayes DF, Luker GD.
Cancer Res. 2008 Jul 15;68(14):5529-32.
PMID: 18632603 [PubMed - indexed for MEDLINE]
Related Articles
20:
Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result.
Kurihara T, Itoi T, Sofuni A, Itokawa F, Tsuchiya T, Tsuji S, Ishii K, Ikeuchi N, Tsuchida A, Kasuya K, Kawai T, Sakai Y, Moriyasu F.
J Hepatobiliary Pancreat Surg. 2008;15(2):189-95. Epub 2008 Apr 6.
PMID: 18392713 [PubMed - indexed for MEDLINE]
Related Articles